During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.
This transcript has been lightly edited for clarity.
T.Y. Alvin Liu, MD: Hello everyone. My name is Alvin Liu. I'm a retina specialist, and I'm on the faculty at the Wilmer Eye Institute, Johns Hopkins Medicine. Today, I have the pleasure of introducing to you our new AI Center at Wilmer.
Recently, we received a very generous donation of $10 million from Dr James B Gills and Mrs. Gills to establish an endowed AI Center at Wilmer, and this will be the first endowed AI center at the Johns Hopkins School of Medicine. I have the honor of being asked to be the inaugural director of the center, together with the endowed professorship. This center will be guided by 3 important core values. Number 1, it will be open to all Wilmer faculty members. Number 2, we will seek to be proactively collaborative with other academic centers, industry and foundations. And Number 3, we will be ready to pivot rapidly in response to the evolving AI landscape.
In terms of specific initiatives, there are 3 major ones. First, we would like to provide a steady stream of computer science talents in terms of AI to our Wilmer faculty members. Number 2, we would like to establish a permanent data storage site to create a digital twin for all the images and videos at Wilmer. And Number 3, we will establish centralized and steady compute resources in terms of access to GPUs. We have many more initiatives to come, so stay tuned and thank you very much.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.